Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07727642) titled 'Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma' on July 22.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Shanghai Public Health Clinical Center
Condition:
AIDS-related Lymphoma
HIV Infection
Intervention:
Drug: Oral Antiretroviral Therapy
Drug: albuvirtide
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: May 26, 2026
Target Sample Size: 60
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/...